Search

Now showing items 191-197 of 197

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.

2014-05- Montes Martínez, Ariadna; Pérez Pampín, Eva; Narváez, Javier; Cañete, Juan D; Navarro-Sarabia, Federico; [et al.]

Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritis.

2012-10- Montes Martínez, Ariadna; Pérez Pampín, Eva; Calaza Cabanas, Manuel; Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio

Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice

2014-07-04- Orosa Puente, Beatriz; Martínez Rial, Paula; González Martínez-Pedrayo, Antonio; Guede, David; Caeiro Rey, José Ramón; [et al.]

Effectiveness of biologic therapy on disease activity in ankylosing spondylitis: a BIOBADASER III observational study

2019- Emperiale, V.; Sanchez-Piedra, C.; Bohorquez, C.; Colazo, M.; Fernandez-Lopez, C.; [et al.]

Survival of jak inhibitors: real-word data from the biobadaser III registry

2019- Emperiale, V.; Sanchez-Piedra, C.; Cuende, E.; Vela-Casasempere, P.; Villegas, M. D. C.; [et al.]

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain

2021- POMBO SUAREZ, MANUEL ENRIQUE; Maneiro Fernández, José Ramón; Gómez-Reino Carnota, Juan Jesús

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment

2019- Genovese, M. C.; van der Heijde, D.; Lin, Y.; St John, G.; Wang, S.; [et al.]

1
. . .
17
18
19
20